Bioxcel Therapeutics's total assets for Q4 2025 were $44.92M, an increase of 0.28% from the previous quarter. BTAI total liabilities were $140.38M for the fiscal quarter, a 4.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.